The table below shows VERTEX PHARMACEUTICALS INC / MA's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
$392.80M
$414.80M
$407.50M
$363.00M
$392.60M
$371.90M
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
VRTX annual revenue (10-K history)
VERTEX PHARMACEUTICALS INC / MA reported annual revenue of $12.00B for fiscal year 2025. That is up 8.9% from $11.02B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.70B (FY 2016) to $12.00B. Figures come from the company's audited annual reports as filed with the SEC.
